Just averaged up ahead of earnings

not the best quarter- revenue down to 5.5, EPS $.11. They did say the new product they were working on will be releasing Q1 2019

5.3 million in backlog next quarter alone, with 7.3 million total. New product launches Q1 2019 so that is July-September of this year?

Not sure if I'm misunderstanding how this backlog works. When they say "scheduled to deliver" in the 4th quarter does that mean they actually expect to deliver it and recognise the revenue next quarter, or does it mean they are supposed to deliver it that quarter but may not manage it because they aren't producing enough?

Also would this backlog include the extra $2.9m order due to deliver in the 4th Q that was mentioned in the last quarterly, or would that not count as backlog since it's not due to go out yet anyway?

backlog is orders placed, but not completed for the client. They expect to complete 5.3mm of work in the next quarter (4Q, 2018) for orders that have already been placed with them. Basically their revenue should be 5.3 million in 4q 2018 + whatever revenue they receive from orders placed and completed in that quarter.
I'm unsure what you mean by the last paragraph. Due to deliver could be money received- but work not completed and I believe that counts as backlog unless specifically stated otherwise.

Thanks. That's actually what I'd always assumed they meant by backlog but I got confused that they have just received an order for $5.7m in fiscal 2019 yet only had a backlog of $2m for 2019... I've just realised that order was received in April so wouldn't play into the backlog as of 31st March.

How does the contract for 150 units a month affect the backlog though? Clearly this doesn't all go down as backlog straight away as they have the contract through 2021 and current backlog all goes out before the end of fiscal 2019. So I guess there must be actual orders sent in accordance with the contract at particular intervals? I.e. maybe they place an order each month for the next month and only 1 months worth is counted as backlog. Or does it never form part of the backlog?

If the client wants the work done in 2019-delivered then it is not backlog. If the client orders it for asap and the company is unable to do it now due to working on other commitments or is in the process of doing it (sometimes-depends on accounting practices) then that is backlog.

Ok so what I am getting at is...

Is this (from the February 10Q) included in the 5.3m backlog or not as it wasn't ordered for ASAP but for a specific date several months later:

"For instance, our largest customer amended a purchase order in January 2018 to increase the order by approximately $2.9 million for products scheduled to be delivered in the fourth quarter of this fiscal year."

That's what I'm really unclear on and makes a huge difference to the revenue we can expect next quarter.

I think so, but the wording of 'scheduled' makes it tricky to know for me. Someone else that knows more could chime in or call the company and ask?

To be honest I don't think that the backlog really matters all that much. Their existing book of business puts out $5 - $5.5 million in revenue a quarter.

What matters is if their proprietary new products are a hit, and if they are, how large the addressable market is and how much revenue these products are potentially worth. If things work out, there is great upside from here.

https://upticknewswire.com/featured-...nasdaq-pdex-5/

Said they have customers now for their new product they private- developed.

Also are ramping up production for their major #1 customer. Purchased a couple more machines to increase that production.

Some of their other customers are asking them to reduce prices in wake of tariffs.

Also, have two new P-Dex branded products in development.

I think on the tariffs it's more so that it's a threat to their margins as its increasing the costs of some of their components from their suppliers.

Either way, sounds like things are going really well. PDEX is my largest position by far, I think this is really going to take off over the next 12 - 18 months.

Loaded up on some more PDEX this week, I’m excited for the upcoming results.

I figure quarterly revenue should be the highest yet (at least over the few years I’ve been in this) with the additional $2.9m from customer 1 due for the 4th quarter. If they can actually deliver that on top of the usual ~$3m from customer 1 and ~$2m from others that would be closing in on $8m. I imagine they may struggle to deliver it all and need to ramp up production to hit these sort of levels, but still hope they could deliver enough to beat the $6.6m from Q3 ‘17.

It's exciting to see this finally taking off a bit again.

It's always rose before earnings and sold off slowly after.
I don't necessarily see a big number for Q4. The CEO said they expect to see the earnings for their new product in the current quarter, Q1.

If they do have a great quarter it will be awesome, as it will be almost all from their normal business line.

Yes the new product sales won’t show up until fiscal ‘19 results. But the largest customer increased their orders by an additional $2.9m for Q4 (was in the 10Q from Feb).

I believe this forms part of the +50% for customer 1 that the CEO mentioned in the recent interview, and I believe it is completely separate from the new products.

Hopefully it is, I know they mentioned expanding that current part of their business. Could also be at the expense of other clients or just have an increased backlog since they hadn't expanded that part of their business yet.

Nice quarter. Revenue up to 6.2 and an increase in gross margin. Market seems to like it very much

I'm not 100% sure, but this might be a bigger win than any single day I had in poker

I saw the increase not realizing they reported yesterday and thought they must have crushed it. Was actually disappointed in the results relative to my expectations. Maybe some fund company just took notice of it? They've reported usually around the 9th to 12th of September in the past.

Yea, same. Shame about the monogram investment. Aside from that I think I expected a bit higher revenue, although probably not as much net income as the adjusted amount.

The 10k has been 13-15th September but last year they released results early in an 8k as well.

This monogram investment. 800k at 4.5% plus preferred share options and one year later they have to write off the loan and basically sell their collateral to recoup some of their investment?

In the grand scheme of things 800k isn't really that big of a deal, and if the company survives they still have the contractual right to manufacture whatever Monogram is developing, so there's still some upside there. But yes, thus far their attempts at getting creative on the financial front haven't really worked out all that well.

The hotel thing worked right?

Lots of volume these last couple days. PDEX seems to have found itself a big buyer. Not that I'm complaining